Infant Incubators Market is estimated to reach a valuation of US$ 327.9 Mn by the end of 2022 | FMI

[250 Pages Report] As per Future Market Insights, the global infant incubators market was valued at around US$ 311.6 Mn in 2021 and is projected to exhibit a CAGR of 4.7% over the forecast period. It is set to reach an estimated valuation of US$ 518.2 Mn in 2032.

Attributes Key Statistics
Global Infant Incubators Market Estimated Size (2022E) US$ 327.9 Mn
Projected Market Valuation (2032F) US$ 518.2 Mn
Value-based CAGR (2022-2032) 4.7%
Collective Value Share: Top 5 Countries (2022) 49.5%

The global infant incubators market is growing due to increased awareness regarding the health of newborns, rising prevalence of chronic infections, and surging cases of sudden unexpected deaths among infants in healthcare facilities. Additionally, the emergence of numerous epidemics and looming health risks they pose have further increased the demand for intensive care incubators across all healthcare facilities, thereby promoting market expansion.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15506

Besides, growing acceptance of infant incubators by various end users, including hospitals, as well as pediatric & neonatal intensive care units, would give the market a boost in the approaching years. The U.S. healthcare sector has been focusing on the importance of collaborative strategies by government bodies, which would boost the advancement in healthcare facilities. The National Network of Perinatal Quality Collaboratives (NNPQC), for instance, was established by the CDC and the March of Dimes to assist state-based PQCs in improving maternal and infant health outcomes statewide in a measurable manner.

These aforementioned factors will boost the market in the near future, as key companies are also concentrating on acquisitions and the development of novel products with improved efficacy in terms of environmental stability, infection protection, and durability.

Key Takeaways from Market Study

  • By product, the intensive care incubators segment held approximately 3% of the global market share in 2021.
  • Based on end user, the hospital segment generated a market share of around 7% in 2021.
  • East Asia is considered to be the leading region in the market and it held a share of 3% in 2021.
  • Europe accounted for a value share of 7% in 2021 owing to increasing number of preterm births in the region.
  • China is projected to exhibit growth at a lucrative CAGR of 8% during the forecast period.

“Increased initiatives by government bodies to promote health safety solutions and growing prevalence of chronic illnesses among infants in healthcare facilities are estimated to propel the market,” says an analyst of Future Market Insights.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15506

Competitive Landscape

Although infant incubator producers are functioning at full capacity, demand has surpassed supply in recent years with the rising prevalence of chronic illnesses. The gap has had an impact on a wide range of end users, including healthcare practitioners and other industrial users.

The global infant incubators market is fragmented, and there are a wide range of regional, up-and-coming, as well as established businesses operating within it. Key stakeholders have started conducting promotional activities to introduce unique infant incubators with improved efficacy.

For instance,

  • In April 2022, nearly two hundred portable incubators that were developed by utilizing technology co-invented by a Stanford MBA more than 10 years ago, were sent to Ukraine to offer life-saving warmth to babies born prematurely in hospitals and bomb shelters.
  • Dräger’s new Ponta and Ambia ceiling supply systems, which went into effect on September 30, 2021, give hospitals a great deal of flexibility when designing workstations that support particular clinical requirements in the operating room, ICU, and NICU.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15506

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Infant incubator market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032. The global infant incubators market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on the product (intensive care incubator, and transport incubator), end users (hospitals, pediatric and neonatal intensive care units, others), across seven key regions of the world.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Intracranial Aneurysm Market at a promising CAGR of 8.8% From 2022 and 2032

[342 Pages Report] The intracranial aneurysm market thrives on a strong CAGR of 8.8%, while it holds a value of US$ 1.2 Bn in 2022 and is anticipated to reach US$ 2.56 Bn.

Attributes Value
Medical device cleaning Market Size (2022) US$ 1.2 Billion
Medical device cleaning Market Projected Size (2032) US$ 2.56 Billion
Medical device cleaning Market Value CAGR (2022-2032) 8.8%

A global study on the intracranial aneurysm market explains that the growing cases of intracranial aneurysms in the brain involve the bulging in the wall of an artery in the brain. It causes swelling, ballooning, and widening.  Aneurysms weaken the walls and make it hard for the nerves to function properly.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15291

The expanding intracranial aneurysm market size is attributed to the new advanced t echnology integrating with intracranial aneurysm treatment and solutions. As the risk of walls bursting increases, end user patients and treatment centers adopt the intracranial aneurysm treatment and solution methods.

Latest technological developments, increasing cases of brain aneurysm & its complications along with the introduction of minimally invasive procedures are gaining traction for the intracranial aneurysm market.

Key Takeaways:

  • The type category has three major segments, Surgical Clipping, Endovascular Coiling, and Flow Diverters. The endovascular coiling segment dominates the market while holding a market share of 85.3% of the global share.
  • The minimally invasive techniques go through the catheter to locate the aneurysm in the brain. Growing hypertension among the geriatric population leads people to a higher chance of brain aneurysms and other diseases.
  • The end user category is dominated by the hospital segment, holding 89.5% of the global market. The segment grows at a promising CAGR of 8.9% through the forecast period, attributed to application of technologically advanced tools in operation theaters and intensive care units along with increased number of healthcare units.
  • North America holds 27% of the global share in the global intracranial aneurysm market in 2022. The growing intracranial aneurysm market in the North American region is attributed to the growing healthcare facilities, government investments, and the rising cases of brain aneurysms.
  • Asia Pacific region is anticipated to thrive at the highest CAGR of 12.7% through 2032. Presence of emerging economies like India and China that are investing huge capital in building their healthcare infrastructure, advancing and making it tech-enabled.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15291

“The Intracranial aneurysm market analysis states that the use of new platforms like Artificial intelligence, big data, and the internet of things (IOT) are integrating with the treatment solutions. Countries such as the U.S., the U.K., and Germany have witnessed a high prevalence of intracranial aneurysms in recent years. Neuro Intervention India states that approximately 6.0 million people in the U.S. develop an unruptured intracranial aneurysm. The treatment of brain aneurysms includes medical therapy, surgical clipping or endovascular therapy, or coiling without or with adjunctive devices, fueling the demand for intracranial aneurysm treatment solutions”  says a Future Market Insights analyst.

Competitive Landscape

The Intracranial aneurysm market has various key competitors that focus on expanding healthcare centers with advanced technology. The key competitors understand and focus on new techniques that are aneurysm-specific and target wall healing and blood prevention. This makes the competitive landscape more dynamic and versatile, owing to the expansion of the intracranial aneurysm market.

The key competitors flourishing in the growth of intracranial aneurysm treatment solutions are Medtronic, Microport Scientific Corporation, B. Braun, Stryker, Johnson and Johnson Services Inc., Microvention Inc., and Codman Neuro (Integra Lifesciences).

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15291

Recent Developments

  • MicroPort Scientific Corporation has introduced new therapies for neurovascular intervention that resolve potential issues related to brain aneurysms, offering specific tools to surgeons. This fuels the sales of intracranial aneurysm treatment solutions.
  • Stryker has added the neuroform atlas stent system that is further used in conjunction with metal coils that help in packing Aneurysms (week walls and blood vessel scar) in the brain. This is anticipated to help multiple surgeons across the globe.

Intracranial aneurysm Market by Segmentation

By Type Outlook:

  • Surgical Clipping
  • Endovascular Coiling
  • Flow Diverters

By Application Outlook:

  • Hospitals
  • Clinics
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

First Aid Market size is anticipated to be US$ 800.38 Million by 2032

Future Market Insights (FMI), in its latest report titled, “China First Aid Market Assessment and Opportunity 2014 – 2020”, projects the China first aid market to exhibit a CAGR of 6.3% between 2015 and 2020. Adoption of aggressive promotional campaigns are key factors driving growth of the market.

The report is focused on basic first aid products such as adhesive bandages, disinfectants and gauzes. Though the basic wound care segment in China accounts for miniscule share of the overall wound care market in China, it is expected to witness significant growth over the next few years. Increasing awareness about non-traditional first-aid products among consumers in Tier 2 and Tier 3 cities is the prime driving factor for the market in the region.

As of 2014, basic first aid products accounted for less than 20% share of the overall wound care market in China. Strategies such as innovative product packaging along with aggressive market campaigning has led to surge in demand for these products in China. Government emphasis on healthcare policies, liberalization of policies related to distribution of licenses and FDI influx are other key driving factors of the first aid market in China. On the flipside, low healthcare expenditure and higher preference for Chinese traditional medicines among consumers is a major restraint for non-traditional wound care product manufacturers.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-cn-659

The report analyses the China first aid market in terms of sales revenue (US$ Mn) by product, cities and by retail sales channel and provides information regarding market dynamics, value chain, competitive landscape, current trends, market estimations and forecast.

On the basis of city, the China first-aid market has been segmented into Tier 1, Tier 2 and Tier 3 Cities. Among Tier 1 cities, Shanghai offers good market opportunities for first-aid products manufacturers. It is anticipated to generate 1.4X higher sales revenue by the end of the forecast period as compared to that in 2014. Disinfectant products are anticipated to account for over half of the sales revenue in Tier 1 cities, followed by gauzes and bandages respectively. Tier 2 cities are expected to generate 1.3X higher revenue than Tier 3 cities by the end of 2020.

Among retail sales channels, drugstores and pharmacies are key channels for sales of adhesive bandages. Hospitals are the key channel for sales of gauzes. Hospitals account for major share of retail sales in Tier 3 cities in China. Though drugstores, pharmacies and hospitals are key retail sales channels for adhesive bandages and gauzes, modern retail sales channel are the most preferred mode for sales of disinfectants. Hypermarkets and supermarkets account for over 60% share of retail sales of disinfectants.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-cn-659

By product type, the China first aid market has been segmented into adhesive bandages, gauzes and disinfectants (antiseptics). While disinfectants are projected to be the largest market segment throughout the forecast period, its presence is limited to Tier 1 and Tier 2 cities in China. The disinfectant products segment is anticipated to register a CAGR of 7.5% between 2014 and 2020. Reckitt Benckiser and Walch are key players in this product segment. Organized players account for significant market share in the disinfectants products segment. Among products, gauzes (woven and non-woven) covers significant market in Tier 3 cities in China. Sales revenue of adhesive bandages is further segmented into butterfly stiches, transdermal bandages and special bandages. Transdermal bandages account for significant market share in the adhesive bandages segment.

Key players in the China first aid market include:

  • Johnson and Johnson
  • Winner Medical Group Co.
  • Reckitt Benckiser
    Yunnan Baiyao
  • 3M Company
  • Nepstar Drugstore
  • 7-Eleven
  • Beijing Hualian Group
  • A.S Watson Group.

Key Segment By Product Type

  • Bandages
  • Gauzes
  • Disinfectants

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 6-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Vaginitis Treatment Drugs Market is projected to progress at 5.2% CAGR to reach US$ 4.52 Billion by the end of 2030

Global vaginitis treatment market is set to reach USD 2.7 Bn in 2020, and witness a CAGR of around 5% during the forecast period (2020 – 2030). These insights are from a latest market research study by Future Market Insights (FMI), an ESOMAR-certified research and consulting firm.

Vaginal infection impacts 40% of women across the globe. Moreover, majority of those infected are asymptomatic. As such, it becomes utterly difficult to keep a track of vaginitis and the treatment to be administered.

The only way out in this regard turns out to be creating awareness about the factors that lead to vaginitis; so that even if major symptoms do not appear; women could at least seek medical advice regarding the same.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11790

Several government-funded and/or private organizations are emphasizing on educating the people regarding vaginitis and the due course of treatment. Oral medications are prevalent in the current scenario.

For instance – DARE-BV1, a new thermosetting hydrogel amass with clindamycin phosphate 2% did receive QIDP (Qualified Infectious Disease Product) designation by US FDA in Aug 2019. The product came from Dare Bioscience, Inc. Such developments are expected to encourage the other players to come up with new products; thereby bolstering the vaginitis treatment drugs market.

Key Takeaways of Vaginitis Treatment Drugs Market Study

  • Nitroimidazole compound is the largest segment by drug type representing 44% of revenue share in the Vaginitis Treatment Drugs Market in 2019.
  • By the schedule of drug, prescription (Rx) drugs contributes for 3/4th of market value share. Over-the-counter drugs (OTC) is expected to grow at a higher growth rate in the forecast period
  • North America and East Asia collectively contributed for more than half of the market share in the Vaginitis Treatment Drugs Market in 2019 with North America holding a noteworthy market share.

“Development of single-dose drugs, growing demand for over-the-counter medication, and increasing recurrence rate of vaginitis will boost the growth of the Vaginitis Treatment Drugs Market,” says the FMI Analyst.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-11790

Partnerships and Collaborations Paving the Way for Vaginitis Treatment Drugs Market

Partnership strengthens the drug portfolio, broadens the consumer base, and gives an impetus to research and development. For instance – in March 2018, Bayer thrush treatment Canesten partnered with sketch comedy group SketchShe and media agency PHD for a campaign which intended to reduce the stigma and embarrassment associated with the condition.

This campaign did give the consumers a fair idea about the BQ (Behavioral Quotient) of both the companies; and also left a lasting impression in the consumers’ minds.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Vaginitis Treatment Drugs Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on Vaginitis Treatment Drugs Market on basis of drug type (nitroimidazole compound, lincosamide antibiotics, triazoles, imidazoles), indication (bacterial vaginitis, fungal vaginitis (yeast infection), trichomoniasis), route of administration (oral, cutaneous, vaginal), schedule of drug (prescription drugs (Rx), over-the-counter drugs (OTC)) distribution channels (hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies) across seven major regions.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/11790

Key SegmentDrug Type

  • Nitroimidazole Compound
  • Lincosamide Antibiotics
  • Triazoles
  • Imidazoles

Indication

  • Bacterial Vaginitis
  • Fungal Vaginitis (Yeast Infection)
  • Trichomoniasis

Route of Administration

  • Oral
  • Cutaneous
  • Vaginal

Route of Administration

  • Oral
  • Cutaneous
  • Vaginal

Schedule of Drug

  • Prescription Drugs (Rx)
  • Over-the-counter Drugs (OTC)

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Mail Order Pharmacies

Regions

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Smart Pill Boxes & Bottles Market to grow at a healthy CAGR of 9.9% From 2022 and 2028

[230 Pages Report] The global smart pill boxes and bottles market was valued at US$ 129.3 Mn in 2021 and is expected to reach US$ 144.2 Mn in 2022. Furthermore, with the increasing adoption of smart pill boxes and bottles to improve medication adherence in patients, the overall smart pill boxes and bottles market is expected to grow at a healthy CAGR of 9.9 percent between 2022 and 2028, totaling more than US$ 254.7 Mn by the end of 2028.

Smart Pill Boxes & Bottles Market Size (2021) US$ 129.3 Mn
Smart Pill Boxes & Bottles Market Size (2022) US$ 144.2 Mn
Smart Pill Boxes & Bottles Market Forecast (2028) US$ 254.7 Mn
Smart Pill Boxes & Bottles Market Growth Rate (2022-2028) 9.9% CAGR
Dominant Product Smart Pill Boxes (75.3%)

Sales of smart pill boxes and bottles are likely to reach around 800 thousand in 2019. According to a new analytical research study by Future Market Insights (FMI), smart pill boxes and bottles market will remain a high growth-low volume landscape over the course of next few years. Over 43% of total sales will be accounted by smart pill boxes. The report envisages a higher rate of adoption for smart pill bottles.

Almost 70% of adult patients are observed to discontinue or manipulate drug therapy, resulting in non-adherence to prescribed medication. The study opines that this directly adds to the economic burden on healthcare delivery system in form of emergency cases and

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1710

Smart Pill Boxes & Bottles Market to grow at a healthy CAGR of 9.9% between 2022 and 2028

Smart pill boxes and bottles are increasingly being perceived as a potential solution to such challenges posed by increased healthcare delivery costs. Significance of medication adherence continues to rise with increasing prevalence of chronic conditions, propelling demand for smart pill boxes and bottles.

Dementia and geriatric care remain the key application areas of smart pill boxes and bottles, according to the report. More than 80% of sales is accounted by aging patients and dementia-afflicted population. Cancer management is likely to emerge lucrative in terms of applicability in coming years.

With surging demand for high-quality healthcare delivery, senior care centers, hospitals, long-term care centers, and homecare settings are accelerating adoption of medication dispensers, thereby elevating the revenue growth of smart pill boxes and bottles market. Some of the leading companies are actively involved in the development of advanced technology medication dispensing devices with zero error risks during medication.

Home care settings maintain the highest consumption share in smart pill boxes and bottles market that roughly equates 65% of total sales. Almost a fifth of smart pill boxes and bottles sold are installed at seniors care and assisted living centers. FMI’s analysis indicates that long-term care centers are also creating promising market opportunities for smart pill boxes and bottles manufacturers and distributors.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1710

North America continues to reign supreme owing to early adoption of advanced technology enabled smart pill boxes and bottles, accounting for more than a third of the global market revenue. European market for smart pill boxes and bottles also represents a substantial volume share, majorly driven by German patients. South and East Asian regions are briskly developing high-potential markets for manufacturers and distributors of smart pill boxes and bottles, says the report.

The vendor landscape of smart pill boxes and bottles market remains fairly consolidated and competitive, as Tier 1 manufacturers continue to account for a majority of share in the market in terms of volume. While dominance of Koninklijke Philips N.V., PharmRight Corporation & Livi, and AdhereTech prevails in smart pill boxes and bottles market, the report finds that the competition among these players is characterized by product innovation, new launches, and technological advancements.

Key Segment

By product type

  • Smart Pill Box
  • Smart Pill Bottles

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1710

By indication

  • dementia
  • Parkinson’s disease
  • cancer management
  • diabetes care
  • geriatric care
  • disability
  • others

By end user

  • Seniors Care & Assisted Living
  • Long Term Care Centers
  • Home Care Settings

By regions

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Tissue Engineered Skin Substitute Market is expected for a robust 9.6% CAGR during 2022 – 2029

[248 Pages Report] Rapid expansion of wound management space has argued well for the growth in demand for tissue engineered skin substitutes. The global tissue engineered skin substitute market is projected for a robust 9.6% CAGR during 2022 – 2029, predominantly driven by high applicability in diabetic foot ulcers and other chronic wounds.

With advent of tissue engineering and improved ability to combine advanced manufacturing technologies with biomaterials and cell culture systems, more biomimetic tissue constructs have been emerged. Technological advancements are leading to production of advanced tissue engineered skin substitutes. 3D bioprinting and biotextile are emerging as popular biofabrication strategies for creating bioengineered skin substitutes. A team of researchers in the U.S. recently discovered a technology for complete 3D printing of the living skin along with blood vessels. Emergence of such revolutionary fabrication technologies will create a massive opportunity in the global market.

Despite breakthrough innovations assisting the growth of market, certain limitations are still there. The inability of tissue engineered skin substitutes to produce skin appendages such as hair follicles, sebaceous glands, and nails continues to remain among the most concerning challenges facing R&D teams

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-781

Key Takeaways – Tissue Engineered Skin Substitute Market Study

  • With increasing researches in tissue engineering, the demand for   biologic skin substitute is expected to increase in the forecast period. For instance, a team of engineers at the California Institute of Technology (Caltech) and ETH Zurich have developed an artificial skin made from pectin, a naturally occurring long-chain molecule present in plant cell walls allowing the construction of natural and new dermis.
  • Increasing prevalence of diabetes and chronic wounds is boosting the demand for tissue engineered skin substitutes.
  • The demand for tissue engineered skin substitutes in emerging economies such as China and India is expected to increase owing to increasing incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

tissue engineered skin substitute market

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-781

Leading Manufacturers Setting the Pace for Product Innovations

The tissue engineered skin substitute market is a consolidated market. The tier 1 companies in the tissue engineered skin substitute market such as Allergan Plc., Mimedex Group Inc., Integra LifeSciences Corp. and Integra LifeSciences Corp. are expected to hold more than half of the total revenue generated by tissue engineered skin substitutes. The key players in the market are reshaping their current product portfolio by focusing on the introduction of new and advanced technologies and innovating new products.

Seeking More Insights?

Tissue engineered skin substitute market, a new study from Future Market Insights, opines on the evolution of tissue engineered substitute market from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of; product (acellular skin substitute, biologic skin substitute, cellular skin substitute and synthetic substitute), material (synthetic and natural), application (chronic wound, acute wound and other applications such as breast reconstruction etc.) and end user (hospital, specialty clinics, ambulatory surgical centres and research laboratories) across seven prominent regions.

Tissue Engineered Skin Substitute Market by Category By Product:

  • Acellular Skin Substitutes
    • Acellular skin substitutes based on Amniotic Membrane
    • Other Acellular skin substitutes
  • Biologic Skin Substitute
    • Allograft
    • Xenograft
  • Cellular Skin Substitutes
    • Cellular skin substitute based on amniotic membrane
    • Other cellular skin substitutes
  • Synthetic Skin Substitutes

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/781

By Material:

  • Synthetic
  • Natural

By Application:

  • Chronic Wounds
    • Venous leg Ulcers
    • Diabetic Foot Ulcer
    • Pressure Ulcers
  • Acute Wounds
    • Traumatic Wounds
    • Burn Cases
  • Other Applications

By End User:

  • Hospital
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Research Laboratory

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Stool Management Systems Market is set to experience significant growth at 3.4% CAGR from 2022 to 2032

According to Future Market Insights (FMI), the demand for stool management systems is expected to rise significantly, reaching a market value of USD$ 166.5 Mn by the end of 2021.

Stool management systems are designed for bed ridden patients with fecal incontinence, a condition commonly known as bowel incontinence. These systems are used to prevent infections and reduce nursing time requirements.

The stool management systems are advantageous for older adults and patients suffering from constipation and fecal incontinence. Furthermore, it is also helpful for bed-ridden patients who may have been subject to aliments such as strokes, paralysis, or spinal injury.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3568

According to the World Bank, approximately 700 million people were aged 65 and above in the world in 2019. Consequently, the overall high incidence of geriatric populations is resulting in the expansion of the patient pool and the resultant increase in the demand for stool management systems globally.

Fecal incontinence issues are common around the world and it has a notable burden on the economy and healthcare systems of society. The condition has impacted the economic system including hospital charges and nursing charges. Stool management systems help in reducing the nursing time and other hospital expenses.

Key players are focusing on strengthening their mergers and acquisition portfolios, in addition to advancement in technologies and new product launches. Europe holds the highest share in the market due to a vast target demographic, the presence of major market players, and high healthcare expenditure in the region.

“Increasing geriatric population, technological advancements, and a rising focus on next-gen stool management systems will create lucrative growth opportunities through 2031,” says the Future Market Insights analyst.

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-3568

Key Takeaways from Stool Management Systems Market Study

  • Systems are key to revenue generation in the stool management systems market surpassing accessories. They are likely to account for 63% value share by the end of the forecast period.
  • Luer-lock syringes will lead, with a valuation of over US$ 16 Bn by the end of 2021 owing to security in drug administration processes.
  • The U.S. accounts for more than 92% share in the North America market, and will witness growth backed by presence of a well-established healthcare sector.
  • Germany and France are leading countries in Europe and will account for more than 18% and 16% of the Europe market respectively in 2021.
  • Australia is the largest and fastest growing market in Oceania, exhibiting 6.2% CAGR during the forecast period.

Who is Winning?

The global stool management systems market is set to expand due to the rising number of people suffering from stool related ailments. Leading organizations within the market are set to focus on research for healthcare systems to offer increasingly effective treatment options for superior patient outcomes.

Some of the leading players in the stool management systems market include B. Braun Melsungen AG, Becton Dickinson, ConvaTec, Inc., Hollister Incorporated, Prosyn International Ltd., Consure Medical and others.

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/3568

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels that provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global stool management systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the stool management systems market on basis of the product type in detail, cover every aspect of the market such as systems, accessories and major regions.

Stool Management Systems Market by CategoryProduct Type

  • Systems
    • External Management Systems
    • Indwelling Collection Systems
      • With Irrigation
      • Without Irrigation
    • Accessories
      • Catheter Tubes
      • Luer-Lock Syringe
      • Collection Bag with Filter
      • Clinch Clamp

Region

  • North America
  • Europe
  • Oceania

About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Cotinine Screening Devices Market is projected to increase at a CAGR of ~4.7% From 2022-2029

According to a new market research report by Future Market Insights, the global cotinine screening devices market was valued at ~US$ 429.9 Mn in 2021, and is expected to increase at a CAGR of ~4.7% during the forecast period of 2022-2029. The report scrutinizes the cotinine screening devices market and provides critical insights for the forecast period of 2022-2029. As per the findings of the report, the global cotinine screening devices market is projected to experience a significant growth over the forecast period, which will be set in motion by a slew of factors such as growing focus on ‘value-driven’ healthcare services and high demand for effective screening techniques.

Stakeholders are leveraging newer technologies to offer non-invasive diagnosis, reliability of the screening devices, as well as testing at desired location, in an attempt to align with the trend of convenience, according to the FMI analyst.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8472

Developing Markets to Reflect New Growth Possibilities

Regions such as North America and Europe are expected to hold prominent market share in terms of value. However, developing markets are expected to project lucrative growth in the global cotinine screening devices market in the forecast period of 2022-2029. The exponential rise in workplace screening is one of the key drivers laying new growth alleys for manufacturers of cotinine screening devices to reap benefits from. The economic and technological parity of developing regions with the developed ones is another chief factor estimated to generate steady sales revenue for market players of cotinine screening devices.

Furthermore, rising level of awareness and adoption of products useful in smoking cessation programs is further upholding the lucrativeness of developing markets such as China, India and Brazil. The factors such as growing prevalence of smoking, screening employees for illicit drugs, sporting events, and deciding the health plan premium are anticipated to surge the sales of cotinine screening devices in developing counties.

The burgeoning middle-class population along with multiple compliances created for recruitment in the armed forces are anticipated to increase the potential use cases of cotinine screening devices in 2022 and beyond. The contract manufacturing services available in developing markets coupled with cheap labor force are expected to boost the investment and attractiveness quotient of developing countries, making them no less than hotbeds of opportunities for growth.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8472

End Users to Show Marked Preferences for Cassettes

By device type, the cassettes are expected to hold prominent value shares of the global cotinine screening devices market. This has majorly resulted from the cost effectiveness, ease of screening, quick detection, and portability of these compact cotinine screening devices. The report features the prominent players in the cotinine screening devices market, whose success has been riding on their strong portfolios and regional presence.

The global cotinine screening devices market is significantly consolidated with a chunk of players commanding prominent shares of the market. These players are offering cotinine screening devices under their popular brands such as Accutest®, ALERE ISCREEN®, Reditest®, QuickProfile™, NicCheck™ I, DrugCheck® SalivaScan™, TobacAlert®, among others.  Mergers and acquisitions will remain one of the key part of the growth & expansion strategies of cotinine screening devices market players, with an extensive emphasis on creating newer business models as well as distribution channels.

Cotinine Screening Devices Market, By Category

Device Type

  • Cassettes
  • Strips
  • Reader

By Sample Type

  • Blood Sample
  • Urine Sample
  • Saliva Sample

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/8472

By End-User

  • Hospitals
  • Laboratories
  • Clinics
  • Workplace Screening Centers

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle-East & Africa

Key Questions Answered in the Report

  • What are cotinine screening devices?
  • What are the key market statistics of the global cotinine screening devices market?
  • Who are the key players of the cotinine screening devices industry?
  • Which device dominates the global cotinine screening devices market?

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Surgical Tourniquets Market is estimated to reach US$ 812.2 by 2029

FMI’ analysis expects the surgical tourniquets market to grow at ~8% CAGR through to 2029, driven a surge in the number of trauma cases over the years lined with rising demand for effective device to stop arterial bleeding during surgical procedures. Analysts also expect that automatic machines and robotic technologies are likely to bring a paradigm shift in operative procedures, which should push the manufacturers to innovate their products and develop strategies to attract and retain a new segment of customers.

Worldwide sales of surgical tourniquets will increase by 7.5% year-over-year to reach ~US$ 381 million in 2019, up from ~US$ 355 million in 2018, according to the latest research from Future Market Insights (FMI).

Surgical tourniquets have long been reliable to establish a bloodless field of operation for surgeons while maintaining a high level of safety for patients. However, the risk of surgical-site infections as well as tourniquet-related injuries, particularly due to the application of high pressures and high pressure gradients to the patient, remains a potential threat to the market growth.

In an attempt to reduce the risks associated with higher tourniquet pressures, manufacturers are placing their bets on products innovations and introduction of novel features such as automatic pressure control, audiovisual alarms, digital displays, and easy-to-use user interface.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2254

Sales of Tourniquet Cuffs to Ramp up in 2019

According to the FMI analysts, tourniquet cuffs have been a vital part of the modern computer-assisted tourniquet system, which accounted for ~77% of total market revenue in 2018. While the inflatable disposable cuffs represented more than half of the total tourniquet cuff sales in 2018, the consumption of inflatable reusable cuffs is likely to increase 7.6% y-o-y in 2019.

“In terms of tourniquet systems, dual channel systems will continue to represent a relatively high share as compared to single channel systems, in the view of enabling bi-lateral procedures or simultaneous surgeries of both upper and lower extremity,” the FMI analyst said.

The consumption of surgical tourniquets for knee arthroplasty accounted for ~31% sales in 2018, while increasing application in amputation of limbs and trauma cases is likely to result in increased market share in the future.

“Recent advancements in reverse shoulder arthroplasty along with the introduction of ‘personalized’ tourniquet systems that allow the use of variable contour design and cuffs for specific patients will open new avenues of growth for the market players,” said the FMI analyst.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2254

Hospitals Capture Significant Share, North America in the Vanguard

In 2018, surgical tourniquets worth ~US$ 176 million were sold in hospitals; according to the FMI analysts, growing number of hospitals, especially in developing countries, and greater awareness of advanced medical devices will continue to drive the consumption of surgical tourniquets in hospitals.

Rapid adoption of ‘value-based’ model in health care settings have led to a surge in the number of ambulatory surgical centers and specialized clinics, thereby paving a new way of growth for the surgical tourniquets market.

The FMI analyst forecasts that North America will continue to remain at the forefront of surgical tourniquets market, representing 30% share in 2018. While North America is likely to be neck-and-neck with Europe to lead the market in future, manufacturers are tapping into new opportunities in developing countries in Asia Pacific.

The surgical tourniquets market shows a fair level of fragmentation, with two prominent players including Zimmer Biomet and Stryker Corporation accounting for more than one-third of the total revenue share. Exploring unmet needs in developing regions and expanding their distribution through collaboration and acquisitions of local and regional manufacturers remain key focal points of the market players.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2254

Key Segment

By Product Type

  • Tourniquet Systems
    • Single Channel Systems
    • Dual Channel Systems
  • Tourniquet Cuffs
  • Inflatable Cuffs
    • Disposable Cuffs
    • Reusable Cuffs
  • Non-Inflatable Cuffs
    • Disposable Cuffs
    • Reusable Cuffs

By Application

  • Knee Arthroplasty
  • Amputation of Limbs
  • Plastic Surgeries
  • Trauma Cases

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

By Region

  • North America
  • Europe
  • Latin America
  • South Asia
  • East Asia
  • Oceania
  • Middle East And Africa
  • Emerging Countries

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Real-time Bioprocess Raman Analyzer Market is projected to reach a valuation of around US$ 50.8 Mn as of 2032

[202 Pages Report] The global demand for real-time bioprocess raman analyzer was valued at 17.8 Mn in 2021 and is expected to grow at a CAGR of 10.1% from 2022 to 2032. According to the study, market sales are expected to reach a valuation of around US$ 50.8 Mn by 2032. In 2021, the instrument segment accounted for more than 90% of the market value share.

Market Outlook:

Data Points Market Insights
Real-Time Bioprocess Raman Analyzer Market Value 2021 US$ 17.8 Mn
Market Value 2022 US$ 19.4 Mn
Market Value 2032 US$ 50.8 Mn
CAGR 2022-2032 10.1%
Market Share of Top 5 Countries, 2021 75.8%

The benefits of Raman spectroscopy as data processing in real-time has made significant contribution as a diagnostic and control tool for pharmaceutical production and bioprocessing, with scientific and financial benefits demonstrated throughout the product life cycle. This has led to the growth of real-time bioprocess Raman analyzers market. Future Market Insights (FMI) in a new study has forecast real-time bioprocess raman analyzers market to expected to exhibit a CAGR of 14.6% during the forecast period (2020-2030).

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6912

Leading market players are focusing on mergers and acquisitions with biopharmaceutical industries and contract manufacturing organizations (CMO). This would help them expand their global footprint. Among end-use segments, contract manufacturing organizations are leading the market, which is then followed by biopharmaceutical companies. Contract manufacturing organizations are anticipated to grow at a CAGR of around 15.9% over the forecast period.

Increasing biopharmaceutical production and reduced cost benefits are expected to fuel Real-time bioprocess Raman Analyzers market growth in the coming decade. The digital transformation for data processing in real-time rising investments into R&D and initiative by regulatory bodies to improvise the development and approval process of biopharmaceutical products and fast track the process is has led to the real-time bioprocess Raman Analyzers market growth.

However, there are few challenges in the real-time bioprocess raman analyzers market like the availability of a skilled workforce which is acting as a restraint in the growth of the market. Lack of information about the product leading to lesser adoption of the Real-time bioprocess Raman Analyzers is acting as a restraint for the market growth.

Key Takeaways from Real-time bioprocess Raman Analyzers Market Study

  • The global Real-time bioprocess Raman Analyzers market is estimated to surpass US$ 8.7 Mn by 2021
  • The U,S, will emerge as dominant market in North America, accounting for over 95% of the overall sales
  • The U.K. will exhibit growth at a positive pace. According to FMI, it is expected to register nearly 20% Y-o-Y growth in 2021
  • Both Germany and France are expected to emerge as attractive markets for realtime bioprocess raman analyzer in Europe
  • Within East Asia, China will account for higher share of proceeds gained by the market

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6912

“Increasing research and development activities are expected to boost the growth for Real-time bioprocess Raman Analyzers Market. On the other hand, there is a rising demand for quality healthcare and pharmaceuticals. This has been creating significant growth opportunities for key players” says the FMI Analyst  

Want more insights?

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Real-time bioprocess Raman Analyzers market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the Real-time bioprocess Raman Analyzers market on basis of a component type (Raman Analysers, Raman Probes, and Software), applications (Lab to Process Analysis and Bioprocess Analysis), and end-users (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Research Organizations) across four major regions.

Who is Winning?

The global market is set to broaden its scope in the forecast period, driven by the increasing adoption rate of real-time and automated solutions during bioprocessing, advancements in technology, and reduced cost in manufacturing of biopharmaceuticals. However, lack of a skilled workforce and inadequate information about the benefits has constrained the sales of Real-time bioprocess Raman Analyzers.

Some of the key players operating in the market are Kaiser Optical Systems (Endress+Hauser), Resolution Spectra Systems Inc. (Merck KGaA), Tornado Spectral Systems, and Sartorius AG. Leading companies are consolidating their positions through mergers, acquisitions, and collaborations.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/6912

Real-time bioprocess Raman Analyzers Market by Category Component Type

  • Instruments
    • Raman Analyzers
    • Raman Probes
  • Software

Application

  • Lab to Process Analysis
  • Bioprocess Analysis

End User

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Research Organizations

Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs